ReviewClinical hematology international2026

Elranatamab in relapsed/refractory multiple myeloma patients on hemodialysis: A real-world case series.

Hikmettullah Batgi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.